Heal Force Leads You to Healthier Life！
E-mail: marketing@healforce.com
EnglishEnglish
  • Company Banner (3)
  • Company Banner (1)
  • Company Banner (4)
You are here: Home / News

Cell Therapy

These are related to the Cell Therapy news, in which you can learn about the updated information in Cell Therapy, to help you better understand and expand Cell Therapy market. Because the market for Cell Therapy is evolving and changing, so we recommend that you collect our website, and we will show you the latest news on a regular basis.
  • Heal Force Cooperates With Pharmaron In the Cell Therapy R&D Base Project

    Heal Force Cooperates With Pharmaron In the Cell Therapy R&D Base Project

    2022-11-11

    Heal Force Group cooperates with Pharmaron, and provides Biological Safety Cabinets and CO2 Incubators for Pharmaron, which helps Pharmaron enter Beijing Yizhuang Cell Therapy Research and Development Pilot Base.Pharmaron is the second-largest drug research and development service provider in China and one of the World's three largest drug research and development service providers. Read More
Leave a Message
Contact With Us

Phone/WhatsApp:

+86-18721088328

Email:

marketing@healforce.com

Address:

Qingpu District, Shanghai, China

About Us

Heal Force integrates R&D, manufacturing, sales and service, focusing on providing you with comprehensive medical and laboratory equipment solutions. Leads you to healthier life, Please free talk with us.

Quick Links

Product Category

Subscribe

Sign up for our news. Be the first to know about the latest Heal Force news. No spam, We promise.
Copyright © 2023​​​​​​​ Heal Force Bio-Meditech Holdings Limited All Rights Reserved. Sitemap I Privacy Policy
We use cookies to enable all functionalities for best performance during your visit and to improve our services by giving us some insight into how the website is being used. Continued use of our website without having changed your browser settings confirms your acceptance of these cookies. For details please see our privacy policy.
×